Compass Pathways PLC
NASDAQ:CMPS

Watchlist Manager
Compass Pathways PLC Logo
Compass Pathways PLC
NASDAQ:CMPS
Watchlist
Price: 4.9314 USD -0.98%
Market Cap: 337.3m USD
Have any thoughts about
Compass Pathways PLC?
Write Note

Intrinsic Value

CMPS's intrinsic value estimate is unreliable because it is based only on its DCF value and doesn't use a relative valuation using multiples.

The intrinsic value of one CMPS stock under the Base Case scenario is 2.8061 USD. Compared to the current market price of 4.9314 USD, Compass Pathways PLC is Overvalued by 43%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CMPS Intrinsic Value
2.8061 USD
Overvaluation 43%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Compass Pathways PLC

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for CMPS cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about CMPS?
Bearish
Neutral
Bullish

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Compass Pathways PLC

Provide an overview of the primary business activities
of Compass Pathways PLC.

What unique competitive advantages
does Compass Pathways PLC hold over its rivals?

What risks and challenges
does Compass Pathways PLC face in the near future?

Summarize the latest earnings call
of Compass Pathways PLC.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Compass Pathways PLC.

Provide P/S
for Compass Pathways PLC.

Provide P/E
for Compass Pathways PLC.

Provide P/OCF
for Compass Pathways PLC.

Provide P/FCFE
for Compass Pathways PLC.

Provide P/B
for Compass Pathways PLC.

Provide EV/S
for Compass Pathways PLC.

Provide EV/GP
for Compass Pathways PLC.

Provide EV/EBITDA
for Compass Pathways PLC.

Provide EV/EBIT
for Compass Pathways PLC.

Provide EV/OCF
for Compass Pathways PLC.

Provide EV/FCFF
for Compass Pathways PLC.

Provide EV/IC
for Compass Pathways PLC.

Show me price targets
for Compass Pathways PLC made by professional analysts.

What are the Revenue projections
for Compass Pathways PLC?

How accurate were the past Revenue estimates
for Compass Pathways PLC?

What are the Net Income projections
for Compass Pathways PLC?

How accurate were the past Net Income estimates
for Compass Pathways PLC?

What are the EPS projections
for Compass Pathways PLC?

How accurate were the past EPS estimates
for Compass Pathways PLC?

What are the EBIT projections
for Compass Pathways PLC?

How accurate were the past EBIT estimates
for Compass Pathways PLC?

Compare the revenue forecasts
for Compass Pathways PLC with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Compass Pathways PLC and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Compass Pathways PLC against its competitors.

Analyze the profit margins
(gross, operating, and net) of Compass Pathways PLC compared to its peers.

Compare the P/E ratios
of Compass Pathways PLC against its peers.

Discuss the investment returns and shareholder value creation
comparing Compass Pathways PLC with its peers.

Analyze the financial leverage
of Compass Pathways PLC compared to its main competitors.

Show all profitability ratios
for Compass Pathways PLC.

Provide ROE
for Compass Pathways PLC.

Provide ROA
for Compass Pathways PLC.

Provide ROIC
for Compass Pathways PLC.

Provide ROCE
for Compass Pathways PLC.

Provide Gross Margin
for Compass Pathways PLC.

Provide Operating Margin
for Compass Pathways PLC.

Provide Net Margin
for Compass Pathways PLC.

Provide FCF Margin
for Compass Pathways PLC.

Show all solvency ratios
for Compass Pathways PLC.

Provide D/E Ratio
for Compass Pathways PLC.

Provide D/A Ratio
for Compass Pathways PLC.

Provide Interest Coverage Ratio
for Compass Pathways PLC.

Provide Altman Z-Score Ratio
for Compass Pathways PLC.

Provide Quick Ratio
for Compass Pathways PLC.

Provide Current Ratio
for Compass Pathways PLC.

Provide Cash Ratio
for Compass Pathways PLC.

What is the historical Revenue growth
over the last 5 years for Compass Pathways PLC?

What is the historical Net Income growth
over the last 5 years for Compass Pathways PLC?

What is the current Free Cash Flow
of Compass Pathways PLC?

Discuss the annual earnings per share (EPS)
trend over the past five years for Compass Pathways PLC.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Compass Pathways PLC

Current Assets 233.7m
Cash & Short-Term Investments 207m
Receivables 13m
Other Current Assets 13.7m
Non-Current Assets 13.7m
PP&E 2.7m
Other Non-Current Assets 10.9m
Current Liabilities 26.2m
Accounts Payable 8.2m
Accrued Liabilities 15.8m
Other Current Liabilities 2.2m
Non-Current Liabilities 28.1m
Long-Term Debt 27.6m
Other Non-Current Liabilities 459k
Efficiency

Earnings Waterfall
Compass Pathways PLC

Revenue
0 USD
Operating Expenses
-168.2m USD
Operating Income
-168.2m USD
Other Expenses
23.9m USD
Net Income
-144.3m USD

Free Cash Flow Analysis
Compass Pathways PLC

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

CMPS Profitability Score
Profitability Due Diligence

Compass Pathways PLC's profitability score is 26/100. The higher the profitability score, the more profitable the company is.

26/100
Profitability
Score

Compass Pathways PLC's profitability score is 26/100. The higher the profitability score, the more profitable the company is.

CMPS Solvency Score
Solvency Due Diligence

Compass Pathways PLC's solvency score is 66/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Negative Net Debt
Low D/E
66/100
Solvency
Score

Compass Pathways PLC's solvency score is 66/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CMPS Price Targets Summary
Compass Pathways PLC

Wall Street analysts forecast CMPS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CMPS is 38.9866 USD with a low forecast of 22.22 USD and a high forecast of 126 USD.

Lowest
Price Target
22.22 USD
351% Upside
Average
Price Target
38.9866 USD
691% Upside
Highest
Price Target
126 USD
2 455% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for CMPS?

Click here to dive deeper.

Dividends

Compass Pathways PLC
does not pay dividends
Shareholder Yield

Current shareholder yield for CMPS is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

CMPS News

Other Videos

Profile

Compass Pathways PLC Logo
Compass Pathways PLC

Country

United Kingdom

Industry

Biotechnology

Market Cap

333.8m USD

Dividend Yield

0%

Description

Compass Pathways Plc functions as an investment holding company. The company is headquartered in Altrincham, Cheshire and currently employs 116 full-time employees. The company went IPO on 2020-09-18. The firm is focused on treatment-resistant depression (TRD). The company is developing COMP360, a psilocybin formulation that includes its pharmaceutical-grade polymorphic crystalline psilocybin, optimized for stability and purity. Its COMP360 psilocybin therapy comprises administration of its COMP360 with psychological support from specially trained therapists with specific professional and educational qualifications. The psilocybin administration session lasts approximately six to eight hours, with patients supported by therapists in a non-directive manner. Psilocybin administration sessions are preceded by preparation sessions, in which patients are given a thorough orientation, and followed by integration sessions to help patients process the range of emotional and physical experiences facilitated by COMP360 administration.

Contact

CHESHIRE
Altrincham
3Rd Floor, 1 Ashley Road, Altrincham
+4416469053974.0
compasspathways.com

IPO

2020-09-18

Employees

116

Officers

CEO & Director
Mr. Kabir Kumar Nath M.A., M.B.A.
General Counsel & Chief Legal Officer
Mr. Matthew Allen Owens
Chief Medical Officer
Dr. Guy Goodwin
CFO, Principal Financial Officer & Principal Accounting Officer
Ms. Teri Loxam M.B.A.
Chief Technology Officer
Dr. Greg Ryslik Ph.D.
Senior Vice President of Investor Relations
Mr. Stephen D. Schultz
Show More
Chief Communications Officer
Mr. Christopher Williams
Chief People Officer
Ms. Anne Benedict
Senior Advisor
Mr. Lars Christian Wilde
Advisor
Dr. Susan C. Stansfield Ph.D.
Show Less

See Also

Discover More
What is the Intrinsic Value of one CMPS stock?

The intrinsic value of one CMPS stock under the Base Case scenario is 2.8061 USD.

Is CMPS stock undervalued or overvalued?

Compared to the current market price of 4.9314 USD, Compass Pathways PLC is Overvalued by 43%.

Back to Top